Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
lorbas's Profile
Displaying 101-150 of 1057 result(s).
CYDY CytoDyn Inc
11/09/2020 7:38:43 AM
How should I know? Could be that th (1)
CYDY CytoDyn Inc
11/09/2020 7:28:48 AM
Only 50m doses will be available in (2)
CYDY CytoDyn Inc
11/09/2020 7:17:43 AM
Therapeutics will be needed for qui (3)
CYDY CytoDyn Inc
11/09/2020 6:57:40 AM
Positive news from Pfizer's vaccine (3)
CYDY CytoDyn Inc
11/08/2020 9:35:59 AM
Yes, that's clear to me... It was a
CYDY CytoDyn Inc
11/08/2020 8:09:07 AM
Whole article: https://www.crainsne (4)
CYDY CytoDyn Inc
11/08/2020 5:10:29 AM
It's from an official interview giv (3)
CYDY CytoDyn Inc
11/06/2020 3:33:46 PM
The trial for severe-to-critical Co (8)
CYDY CytoDyn Inc
11/06/2020 9:46:19 AM
"A Cooperative Research and Develop
CYDY CytoDyn Inc
11/05/2020 5:40:55 PM
CYDY CC cliff notes (incomplete) > (18)
CYDY CytoDyn Inc
11/05/2020 5:35:02 PM
Makes sense, with 3 mTNBC patients (4)
CYDY CytoDyn Inc
11/05/2020 5:17:50 PM
Yes, but they might be eligible for
CYDY CytoDyn Inc
11/05/2020 4:53:38 PM
If only they could have known 4 mon (11)
CYDY CytoDyn Inc
11/05/2020 4:36:48 PM
Oh come on, stop deleting the littl (2)
CYDY CytoDyn Inc
11/05/2020 4:10:41 PM
21th century, here we come! (1)
CYDY CytoDyn Inc
11/05/2020 3:15:51 PM
247 (3)
CYDY CytoDyn Inc
11/05/2020 12:52:32 PM
Unfortunately, it isn't listed unde
CYDY CytoDyn Inc
11/05/2020 5:38:32 AM
https://abc6onyourside.com/amp/new (10)
CYDY CytoDyn Inc
10/30/2020 9:36:21 AM
Mixed DSMC rec for REGN: https://in (3)
CYDY CytoDyn Inc
10/28/2020 5:18:40 PM
https://investor.regeneron.com/new (1)
CYDY CytoDyn Inc
10/26/2020 11:47:17 AM
SH wil understand... http://investo (6)
CYDY CytoDyn Inc
10/25/2020 7:25:13 PM
Exactly. Even the most useless drug (3)
CYDY CytoDyn Inc
10/25/2020 10:28:11 AM
When NP quoted the DSMC recommendat (2)
CYDY CytoDyn Inc
10/24/2020 11:43:07 AM
Exactly, well stated!
CYDY CytoDyn Inc
10/23/2020 4:29:45 PM
Yeah... the good old times. "First (1)
CYDY CytoDyn Inc
10/23/2020 3:58:04 PM
Agree mostly. We need 3 to go to th (1)
CYDY CytoDyn Inc
10/23/2020 3:33:48 PM
- COVID-19: FDA can see unblinded i (8)
CYDY CytoDyn Inc
10/23/2020 2:28:53 PM
I agree it is unlikely. However, th (7)
CYDY CytoDyn Inc
10/23/2020 1:02:12 PM
What's the likelihood that they hit (4)
CYDY CytoDyn Inc
10/23/2020 12:23:16 PM
Disagree. I think it was stat sig, (8)
CYDY CytoDyn Inc
10/23/2020 11:14:53 AM
Whatever happened to the applicatio (1)
CYDY CytoDyn Inc
10/23/2020 2:25:47 AM
No. Unless sponsored by NIH, window (1)
CYDY CytoDyn Inc
10/22/2020 6:28:36 PM
If the SOC treatment protocol in th (6)
CYDY CytoDyn Inc
10/21/2020 5:43:12 PM
PR out https://www.cytodyn.com/news (6)
CYDY CytoDyn Inc
10/20/2020 3:05:27 PM
It doesn't put a strain on 15 sites (3)
CYDY CytoDyn Inc
10/20/2020 12:32:35 PM
Death rate for critical cases is st (8)
CYDY CytoDyn Inc
10/20/2020 8:50:29 AM
Interesting. Thanks! (1)
CYDY CytoDyn Inc
10/20/2020 8:24:29 AM
To my knowledge e.g. the dexamethas (1)
CYDY CytoDyn Inc
10/20/2020 8:07:37 AM
https://www.prnewswire.com/news-re
CYDY CytoDyn Inc
10/20/2020 7:35:51 AM
Playing with some numbers for 75% e
CYDY CytoDyn Inc
10/20/2020 6:12:54 AM
Encouraging news. Important points: (11)
CYDY CytoDyn Inc
10/20/2020 6:09:09 AM
CytoDyn Receives Positive DSMC Reco (4)
CYDY CytoDyn Inc
10/19/2020 4:26:44 AM
Yes, but maraviroc, even if taken f (5)
CYDY CytoDyn Inc
10/17/2020 1:00:03 PM
After WHO study, Gilead might want
CYDY CytoDyn Inc
10/16/2020 3:04:14 PM
A change in endpoints for a disease (7)
CYDY CytoDyn Inc
10/16/2020 9:00:26 AM
Legalese, plus NP loves the word po
CYDY CytoDyn Inc
10/15/2020 4:25:23 PM
What a shocker... Testing the same (6)
CYDY CytoDyn Inc
10/15/2020 10:06:50 AM
All-cause mortality at Day 14 < Tim
CYDY CytoDyn Inc
10/15/2020 9:44:41 AM
That is irrelevant for the study ou (1)
CYDY CytoDyn Inc
10/14/2020 2:05:11 PM
Dr Seethamraju's presentation https (4)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Revolutionizing Funnel Creation: How AI is Changing the Game
  • Stéphane Stoll's Journey to CFO of Bouygues Group Unveiled
  • Enhancing Civic Engagement Through Real-Time Feedback Solutions
  • ACTFORE's Innovative Patent: Transforming Data Extraction Practices
  • Hankook's Thrilling Role as Tire Supplier for WRC Rally
  • Trump Challenges Canada on Palestine Support Amid Trade Talks
  • Sadhguru's Call for Meditation at Tomorrowland 2025 Festival
  • Ultromics Secures $55M to Revolutionize Heart Failure Detection
  • Intellistake and PowerBank Forge Alliance for Digital Asset Innovation
  • Enhancing Cybersecurity in Healthcare Through Effective Strategies
  • J.C. Flowers Expands Portfolio with Caleas Insurance Acquisition
  • Sylva Project Launches v1.4 with Innovative Host Based Routing
  • Enhanced Maternity Care: A Leap Forward with Oracle Health
  • Performance Brokerage Services Facilitates Sale of Edmundson RV
  • Epic Crossover: Ladybug Joins Talking Tom in Hero Dash!
  • Enhancing Chemistry Research: The Launch of Reaxys AI Search
  • PowerBank and Intellistake Forge Game-Changing Alliance
  • Empowering Women: The Launch of Female Sea Rangers in Marine Conservation
  • Verizon Plans to Redeem Notes in September 2025: Key Details
  • Top Five Stocks to Keep an Eye On This Week's Market Trends
  • Ericsson and SoftBank Strengthen 4G and 5G Partnership
  • Endeavour Mining Reports Impressive H1-2025 Financials
  • Exosens Announces New Share Buyback Initiative for Growth
  • Jim Cramer Praises Zuckerberg and Nadella After Earnings Wins
  • Crédit Agricole Assurances Achieves Record Growth and Net Inflows
  • Liven AS Reports Continued Growth and Future Project Updates
  • Ericsson and SoftBank Strengthen Collaboration for Future Networks
  • Forecasting Growth in the Superconducting Wire Market
  • Ericsson Strengthens 5G Alliance with SoftBank for Enhanced Coverage
  • Rising Labour Costs Impacting UK Manufacturing Growth Potential
  • Crédit Agricole Assurances Posts Strong Growth with Record Premiums
  • Quadient Partners with Shell for Smart Locker Expansion in UK
  • Exosens Initiates Strategic Share Buyback Initiative
  • Liven AS Sees Growth in Residential Projects Amid Market Recovery
  • Air France-KLM Releases Comprehensive Financial Report 2025
  • Immunocore Prepares for Financial Results Announcement Soon
  • ICG Enterprise Trust Engages in Strategic Share Buyback Initiative
  • Unibail-Rodamco-Westfield Delivers Impressive H1-2025 Earnings
  • Unibail-Rodamco-Westfield Shows Strong Results for H1 2025
  • CPP Investments Transfers Birmingham Joint Ventures to Hammerson
  • Arm Holdings: A Strategic Shift in AI Chip Development Amidst Competition
  • Tetragon Financial Group's Performance Insights for June 2025
  • OpenWay Shines in Datos Insights' Matrix as Industry Leader
  • Tuniu Corporation Financial Preview: Q2 Earnings Call Ahead
  • Discover Airfide's Revolutionary Wi-Fi HaLow Sensor Technology
  • Vantiva Reports Strong Financial Growth in H1 2025
  • Euronext Announces Voluntary Exchange Offer for ATHEX Shares
  • NB Private Equity Partners Enhances Shareholder Value Initiative
  • Euronext's Strategic Move to Acquire Hellenic Exchanges Shares
  • Innovations in Graphene: Argo Graphene's New Venture with Ceylon
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site